DE68913402D1 - Antikörper mit hoher Affinität für Methamphetamine sowie geeignetes Immunogen für seine Herstellung. - Google Patents

Antikörper mit hoher Affinität für Methamphetamine sowie geeignetes Immunogen für seine Herstellung.

Info

Publication number
DE68913402D1
DE68913402D1 DE89116185T DE68913402T DE68913402D1 DE 68913402 D1 DE68913402 D1 DE 68913402D1 DE 89116185 T DE89116185 T DE 89116185T DE 68913402 T DE68913402 T DE 68913402T DE 68913402 D1 DE68913402 D1 DE 68913402D1
Authority
DE
Germany
Prior art keywords
methamphetamines
antibodies
production
high affinity
suitable immunogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE89116185T
Other languages
English (en)
Other versions
DE68913402T2 (de
Inventor
Jinsei Miyazaki
Makoto Taketani
Tadayasu Mitsumata
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Panasonic Holdings Corp
Original Assignee
Matsushita Electric Industrial Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Matsushita Electric Industrial Co Ltd filed Critical Matsushita Electric Industrial Co Ltd
Publication of DE68913402D1 publication Critical patent/DE68913402D1/de
Application granted granted Critical
Publication of DE68913402T2 publication Critical patent/DE68913402T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531Production of immunochemical test materials
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
    • A61K47/64Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
    • A61K47/646Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent the entire peptide or protein drug conjugate elicits an immune response, e.g. conjugate vaccines
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/44Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material not provided for elsewhere, e.g. haptens, metals, DNA, RNA, amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Analytical Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
DE68913402T 1988-09-02 1989-09-01 Antikörper mit hoher Affinität für Methamphetamine sowie geeignetes Immunogen für seine Herstellung. Expired - Fee Related DE68913402T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP22093188 1988-09-02

Publications (2)

Publication Number Publication Date
DE68913402D1 true DE68913402D1 (de) 1994-04-07
DE68913402T2 DE68913402T2 (de) 1994-09-29

Family

ID=16758799

Family Applications (1)

Application Number Title Priority Date Filing Date
DE68913402T Expired - Fee Related DE68913402T2 (de) 1988-09-02 1989-09-01 Antikörper mit hoher Affinität für Methamphetamine sowie geeignetes Immunogen für seine Herstellung.

Country Status (3)

Country Link
US (1) US5026827A (de)
EP (1) EP0359063B1 (de)
DE (1) DE68913402T2 (de)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5101015A (en) * 1989-04-10 1992-03-31 Abbott Laboratories Reagents for an amphetamine-class fluorescence polarization immunoassay
US5492841A (en) * 1994-02-18 1996-02-20 E. I. Du Pont De Nemours And Company Quaternary ammonium immunogenic conjugates and immunoassay reagents
ATE254930T1 (de) * 1995-03-31 2003-12-15 Xenova Res Ltd Hapten-träger-konjugate zur anwendung in der drogen-missbrauchs-therapie
US5840307A (en) * 1995-03-31 1998-11-24 Immulogic Pharmacuetical Corp. Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation
US6716452B1 (en) * 2000-08-22 2004-04-06 New River Pharmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
WO2005032474A2 (en) * 2003-09-30 2005-04-14 New River Pharmaceuticals Inc. Pharmaceutical compositions for prevention of overdose or abuse
US8394813B2 (en) * 2000-11-14 2013-03-12 Shire Llc Active agent delivery systems and methods for protecting and administering active agents
US7375082B2 (en) * 2002-02-22 2008-05-20 Shire Llc Abuse-resistant hydrocodone compounds
US20070066537A1 (en) * 2002-02-22 2007-03-22 New River Pharmaceuticals Inc. Compounds and compositions for prevention of overdose of oxycodone
US20060014697A1 (en) * 2001-08-22 2006-01-19 Travis Mickle Pharmaceutical compositions for prevention of overdose or abuse
US7338939B2 (en) * 2003-09-30 2008-03-04 New River Pharmaceuticals Inc. Abuse-resistant hydrocodone compounds
US7169752B2 (en) * 2003-09-30 2007-01-30 New River Pharmaceuticals Inc. Compounds and compositions for prevention of overdose of oxycodone
IL163668A0 (en) * 2002-02-22 2005-12-18 New River Pharmaceuticals Inc Use of peptide-drug conjugation to reduce inter-subject variability ofdrug serum levels
AU2003219863C1 (en) * 2002-02-22 2009-03-05 Shire Llc Novel sustained release pharmaceutical compounds to prevent abuse of controlled substances
US7659253B2 (en) * 2002-02-22 2010-02-09 Shire Llc Abuse-resistant amphetamine prodrugs
US7700561B2 (en) * 2002-02-22 2010-04-20 Shire Llc Abuse-resistant amphetamine prodrugs
US7105486B2 (en) * 2002-02-22 2006-09-12 New River Pharmaceuticals Inc. Abuse-resistant amphetamine compounds
KR101159477B1 (ko) * 2003-05-29 2012-07-02 샤이어 엘엘씨 남용 방지성 암페타민 화합물
US6991911B2 (en) * 2003-12-15 2006-01-31 Dade Behring Inc. Assay for entactogens
US20050130243A1 (en) * 2003-12-15 2005-06-16 Zheng Yi F. Assay for entactogens
US7022492B2 (en) * 2003-12-15 2006-04-04 Dade Behring Inc. Ecstasy haptens and immunogens
US7115383B2 (en) * 2004-03-22 2006-10-03 Dade Behring Inc. Assays for amphetamine and methamphetamine
US7037669B2 (en) * 2004-03-22 2006-05-02 Dade Behring Inc. Assays for amphetamine and methamphetamine using stereospecific reagents
GB2404022B (en) * 2004-06-14 2005-08-10 Cozart Bioscience Ltd Competitive assays for the detection of methamphetamine group drugs
GB2404023B (en) 2004-07-02 2005-07-06 Cozart Bioscience Ltd Delta-9-tetrahydrocannabinol detection method
CN105385660A (zh) * 2015-11-03 2016-03-09 杭州隆基生物技术有限公司 一种杂交瘤细胞株及其分泌的抗体和制备方法、应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3996344A (en) * 1972-05-15 1976-12-07 Biological Developments, Inc. Phenethylamine antigenic conjugates, their preparation, antibodies and use
US3878187A (en) * 1972-09-11 1975-04-15 Syva Co Polypeptide derivatives of amphetamine and analogs for immunoassays
EP0311383B1 (de) * 1987-10-09 1993-10-06 Ube Industries, Ltd. Monoklonaler Antikörper gegen Methamphetamin, seine Herstellung, Testverfahren und Testsatz für Methamphetamin

Also Published As

Publication number Publication date
EP0359063A3 (en) 1990-04-04
EP0359063A2 (de) 1990-03-21
US5026827A (en) 1991-06-25
DE68913402T2 (de) 1994-09-29
EP0359063B1 (de) 1994-03-02

Similar Documents

Publication Publication Date Title
DE3581578D1 (de) Antikoerper, herstellung und verwendung.
DE3882550D1 (de) Tabletten, die mit gelatine ueberzogen sind und verfahren zu ihrer herstellung.
BR1100843A (pt) Mak 195, linha celular hìbrida, processo de preparação de anticorpos monoclonais mak 195, aplicação do anticorpo monoclonal mak 195
ATE195323T1 (de) Anti-lymphotoxin-antikörper, herstellung und verwendung
DE3765211D1 (de) Stabilisierter zirconocen/aluminoxan-katalysator und verfahren zur herstellung desselben.
DE3480794D1 (de) Reaktivfarbstoffe, deren herstellung und verwendung.
NO870770L (no) FremgangsmŸte for fremstilling av monoklonale antistoffer.
FI853283A7 (fi) Uudet monoklonaaliset glykokonjugaattien vasta-aineet, menetelmät niiden tuottamiseksi, ja niiden käytöt.
DE68915329D1 (de) Adsorbens,das eine Beschichtung von Polyethylenimin derivatisiert mit hydrophoben Gruppen beinhaltet ; seine Herstellung und Anwendung für Immuntests und Separationen.
DE3785967D1 (de) Monoklonale antikoerper gegen c5a und des-arg74-c5a, ihre herstellung und ihre verwendung.
DE3581806D1 (de) Optische faser und verfahren zur herstellung derselben.
DE3788148D1 (de) Monoklonale Antikörper und deren Verwendung.
DE3485054D1 (de) Candida albicans zytoplasmaantigen, monoklonale antikoerper dagegen und verfahren zur herstellung.
FR2712586B1 (fr) Train pyrotechnique et son procédé de fabrication.
NL186973C (nl) Polymeer-mengvezel en werkwijze ter bereiding daarvan.
DE68911142D1 (de) Olefinoligomere mit schmierungseigenschaften und verfahren zu ihrer herstellung.
DE3682491D1 (de) Immobilisierter c-peptid-antikoerper, seine herstellung und verwendung.
DE3884731D1 (de) Monoklonaler Antikörper gegen Methamphetamin, seine Herstellung, Testverfahren und Testsatz für Methamphetamin.
DE3778102D1 (de) Waermebestaendige zirkonylphosphat-zirkoniumsilikat-verbundkoerper mit niedriger ausdehnung und verfahren zu ihrer herstellung.
DE3583891D1 (de) Monoklonaler menschlicher anti-igg-koerper und verfahren zu seiner herstellung.
DE69430031D1 (de) Immunologische Bestimmungsmethode für eine Pyrethroidverbindung, Haptenverbindung, Zwischenstufe für die Haptenverbindung, Immunogen und Antikörper
DE3583296D1 (de) Oncofetal spezifische monoklonale antikoerper, deren herstellung und verwendung.
AT399885B (de) Verfahren zur herstellung von zellinien, die monoklonale antikörper produzieren
DE3782599D1 (de) Laser mit monolitisch integrierten, planaren elementen und verfahren zu deren herstellung.
DE3574601D1 (de) Antitetanus-antikoerper herstellender human-human-hybridoma und verfahren zu seiner herstellung.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8320 Willingness to grant licences declared (paragraph 23)
8339 Ceased/non-payment of the annual fee